Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Iot symbols : Legn save search
Legend Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
Published: 2022-03-18 (Crawled : 23:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 0.1%
H: 2.28%
C: -1.31%
financial results report results biotech iot
Legend Biotech Announces Preliminary Results for the Year Ended December 31, 2021
Published: 2022-02-18 (Crawled : 14:30) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 0.03%
H: 2.65%
C: -1.66%
ces results biotech iot
Legend Biotech Announces FDA Clinical Hold of its Phase 1 Clinical Trial for LB1901
Published: 2022-02-15 (Crawled : 15:30) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: -4.15%
H: 6.75%
C: 6.65%
lb1901 clinical hold fda trial phase 1 biotech iot phase 2 phase 3
Legend Biotech Achieves Milestone Payments in BCMA CAR-T Collaboration with Janssen
Published: 2022-02-11 (Crawled : 14:30) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
car-t one collaboration biotech iot milestone
Legend Biotech to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-04 (Crawled : 16:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
health thc conference j.p. morgan healthcare conference biotech iot
Legend Biotech Announces Appointment of Dr. Ying Huang to the Board of Directors
Published: 2021-12-30 (Crawled : 16:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: -0.3%
H: 5.62%
C: 5.58%
biotech iot
Legend Biotech to Host Hybrid KOL Event Detailing CARTITUDE Data from the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-07 (Crawled : 14:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: -0.09%
H: 9.78%
C: 8.43%
ema biotech iot
Legend Biotech Announces Submission of New Drug Application to Japanese Regulatory Authority for BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed or Refractory Multiple Myeloma by Janssen
Published: 2021-12-06 (Crawled : 14:30) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 2.7%
H: 0.0%
C: 0.0%
new drug treatment application car-t drug therapy biotech iot submission cel
Legend Biotech Reports Third Quarter 2021 Financial Results and Recent Highlights
Published: 2021-11-16 (Crawled : 14:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 8.65%
H: 8.11%
C: 0.3%
financial results results biotech iot
Legend Biotech Showcases Updated and New Data from Comprehensive BCMA CAR-T, Cilta-Cel, Program and First Preclinical Results for Tri-specific CAR-T at 2021 ASH
Published: 2021-11-04 (Crawled : 14:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: -1.14%
H: 1.45%
C: -4.71%
car-t results biotech iot preclinical cel pre-clinical
Legend Biotech to Host R&D Day on October 18, 2021
Published: 2021-09-22 (Crawled : 14:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: -1.03%
H: 2.71%
C: 1.09%
biotech iot
Legend Biotech to Participate in the 19th Annual Morgan Stanley Global Healthcare Conference
Published: 2021-08-30 (Crawled : 13:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 1.46%
H: 0.17%
C: -1.46%
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 3.63%
H: 1.26%
C: -0.21%
biotech iot conference
Legend Biotech Reports Second Quarter 2021 Financial Results and Recent Highlights
Published: 2021-08-23 (Crawled : 13:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 4.23%
H: 3.94%
C: 1.29%
financial results results biotech iot
Legend Biotech Reports First Quarter 2021 Financial Results and Recent Highlights
Published: 2021-05-18 (Crawled : 13:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 0.81%
H: 14.65%
C: 13.32%
financial results results biotech iot
Legend Biotech Announces Submission of European Marketing Authorisation Application for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2021-04-30 (Crawled : 12:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: -0.37%
H: 0.8%
C: 0.33%
treatment europe therapy car-t biotech iot submission cel
Legend Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Business Update
Published: 2021-03-18 (Crawled : 12:00) - biospace.com/
LEGN | News | $45.205 -4.73% -4.97% 1.1M
|
Health Technology
|
| O: 0.67%
H: 1.19%
C: -7.82%
financial results results biotech iot
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.